
Innovation comes to Alzheimer’s disease
Oncovision has developed CAREMIBRAIN ® a revolutionary brain-dedicated PET that evaluates, with unprecedented accuracy, cerebral function and local activity at key regions, providing early diagnosis of neurodegenerative disorders, cognitive decline, brain tumors, vascular, functional and psychiatric diseases, supporting also healthy aging programs.
Discover more about the project

Oncovision.
Innovative Medical Imaging
Oncovision is a leading provider of innovative medical imaging devices used by surgeons, radiologists, oncologists and nuclear physicians for the diagnosis and treatment of cancer.
Oncovision has extensive experience in the development and commercialization of medical imaging equipment based on nuclear medicine techniques.
CareMiBrain project participants are:
CareMibrain has been developed in collaboration with different partners.

University of Gothenburg

University College London

Universitätsklinikum Tübingen

Massachusets General Hospital

Hospital Clínico Universitario y Politécnico La Fe

Hospital Clínico San Carlos

Instituto de Biomecánica de Valencia

Institute for Instrumentation in Molecular Imaging (I3M) – Polytechnic University of Valencia (UPV)
CaremiBrain project has appeared in several scientific publications
Stay informed about CareMiBrain
Project Coordinator
Constantino Morera
Email Us
info@oncovision.com
Office
Calle Jerónimo de Monsoriu, 92 bajo izq. 46022 Valencia (Spain)